VR Logo

Unrated

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund - Direct Plan


1 Lakh

Investment Grown to
₹ 1.59 Lakh

₹ 10000

Monthly SIP Grown to
₹ 1.47 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 4.91 0.16 1.85 11.09 3.55 16.89 58.74 -- -- -- --
S&P BSE Healthcare TRI 6.78 0.45 2.48 12.49 5.93 17.33 55.61 -- -- -- --
Equity: Sectoral-Pharma 5.60 0.48 2.05 11.47 4.66 16.72 54.38 -- -- -- --
Rank within category 6 9 6 6 9 6 3 -- -- -- --
Number of funds in category 9 9 9 9 9 9 9 4 4 3 0

As on 19-Apr-2021

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund - Direct Plan  | Invest Now
Unrated
Jul-18 58.74 -- -- 1.45 2,214
Nippon India Pharma Fund - Direct Plan
Unrated
Jan-13 54.48 25.04 15.95 0.82 4,261
SBI Healthcare Opportunities Fund - Direct Plan  | Invest Online
Unrated
Jan-13 55.57 21.01 9.59 1.11 1,564
Mirae Asset Healthcare Fund - Direct Plan  | Invest Online
Unrated
Jul-18 59.09 -- -- 0.50 1,269
DSP Healthcare Fund - Direct Plan  | Invest Online
Unrated
Nov-18 68.73 -- -- 0.73 1,110

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 23.22 01-Apr-2020 - 09-Apr-2020 -11.63 11-Mar-2020 - 18-Mar-2020
Month 35.24 27-Mar-2020 - 27-Apr-2020 -20.44 20-Feb-2020 - 23-Mar-2020
Quarter 50.94 23-Mar-2020 - 22-Jun-2020 -13.70 23-Dec-2019 - 23-Mar-2020
Year 94.27 23-Mar-2020 - 23-Mar-2021 -10.86 28-Aug-2018 - 28-Aug-2019

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund -- -- -- -- -- --
S&P BSE Healthcare TRI* 19.45 23.41 0.64 1.40 -- --
Equity: Sectoral-Pharma* 21.90 20.97 0.83 1.71 0.87 4.39
Rank within category -- -- -- -- -- --
Number of funds in category -- -- -- -- -- --

The Risk Measures have been calculated using calendar month returns for the last three years.

As on

* As on 31-Mar-2021

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 30
Top 10 Stocks (%) 63.56
Top 5 Stocks (%) 42.18
Top 3 Sectors (%) 96.64
Portfolio P/B Ratio 3.53
Portfolio P/E Ratio 27.78

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 32,514 39,502
Giant (%) 11.63 11.45
Large (%) 43.57 50.56
Mid (%) 30.07 28.47
Small (%) 14.67 9.52
Tiny (%) 0.05 0.05

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
equal Sun Pharmaceutical Inds. Healthcare 63.76 12.05 9.02 10.91
equal Cipla Healthcare 34.12 12.21 7.98 9.73
up Divi's Laboratories Healthcare 54.00 9.23 2.22 8.62
up Alkem Laboratories Healthcare 21.41 7.80 0.00 6.54
up Dr. Reddy's Lab Healthcare 38.00 9.83 1.47 6.38
up Ipca Laboratories Healthcare 25.89 6.26 0.44 6.20
up Lupin Healthcare 42.03 9.42 3.22 4.58
up Sanofi India Healthcare 37.41 4.83 2.99 4.13
equal Fortis Healthcare Healthcare -- 3.25 0.00 3.25
up Indoco Remedies Healthcare 40.09 3.47 0.00 3.22
up Cadila Healthcare Healthcare 29.23 9.43 2.92 3.07
up Torrent Pharmaceuticals Healthcare 35.36 5.00 1.92 2.90
up Aster DM Healthcare Healthcare 42.49 3.30 0.18 2.86
up Natco Pharma Healthcare 34.04 3.87 0.00 2.32
equal Narayana Hrudayalaya Healthcare -- 3.11 0.12 1.90
down JB Chemicals & Pharma Healthcare 24.57 4.18 0.89 1.89
down Biocon Healthcare 79.88 7.98 1.88 1.88
equal SBI Life Insurance Company Financial 62.30 6.04 1.84 1.87
new Aurobindo Pharma Healthcare 10.51 1.84 0.00 1.84
equal Syngene International Healthcare 65.47 3.02 0.00 1.64
down Tata Chemicals Chemicals 2.80 5.58 0.00 1.42
equal Gufic Biosciences Healthcare 29.48 1.55 0.00 1.34
equal Healthcare Global Enterprises Healthcare -- 1.19 0.00 1.19
equal Dishman Carbogen Amcis Healthcare 49.60 3.82 1.07 1.07
up Shilpa Medicare Healthcare 17.72 0.91 0.00 0.91

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Mar-2021

Fund Manager

— Dharmesh Kakkad since 02-May-2020

Education: Mr. kakkad is B.com., CA & CFA.

Experience: He is associated with ICICI Prudential Asset Management Company Limited from June 2010. Prior to working in Dealing function, he was working in the Operations Department of ICICI Prudential AMC.

Funds Managed:


0.16%

Change from previous, NAV as on 19-Apr-2021

Growth: ₹ 19.2400

IDCW: ₹ 17.6300


Investment Strategy

The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.

Investment Details

Minimum Investment (₹) 5,000
Minimum Addl Investment (₹) 1,000
Minimum SIP Investment (₹) 100
Minimum No of Cheques 6
Minimum Withdrawal (₹) 1
Minimum Balance (₹) --
Lock-in Period Not Applicable
Exit Load 1% for redemption within 15 days

Basic Details

Fund House: ICICI Prudential Mutual Fund
Launch Date: 13-Jul-2018
Return Since Launch: 26.65%
Benchmark: S&P BSE Healthcare TRI
Riskometer: Very High
Type: Open-ended
Assets: ₹ 2,214 Cr (As on 31-Mar-2021)
Expense: 1.45% (As on 28-Feb-2021)
Risk Grade: --
Return Grade: --
Turnover: 50.00%

Most Recent Dividends

Plan Record Date Dividend (₹ / Unit)  
IDCW05-Aug-20201.3000

Contact Information

AMC: ICICI Prudential Asset Management Company Ltd

Address: One BKC , A Wing , 13th Floor, Bandra Kurla Complex, Mumbai - 400051

Phone: 022-26525000 / 1800-222-999 / 1800-200-6666

Fax: 022-26528100

Email: [email protected]

Website: http://www.icicipruamc.com

Registrar & Transfer Agent: Computer Age Management Services Ltd.

Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002

Phone: 1800-3010-6767 / 1800-419-7676

Fax: 044-30407101

Email: [email protected]

Website: www.camsonline.com

Upcoming Video

Investors' Hangout

How to optimise returns with measured risk

DateFriday, 23-Apr-2021
Time12:30 PM - 01:00 PM